Zydus Lifesciences Ltd. - Research Center
532321 ZYDUSLIFE Group (A) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Sales | 5,115.00 | 4,379.70 | 3,849.60 | 4,132.30 | 3,852.80 |
| Operating profit | 1,790.40 | 1,223.30 | 816.20 | 1,101.90 | 1,216.80 |
| Interest | 180.60 | 104.70 | 66.60 | 68.30 | 34.80 |
| Gross profit | 2,226.70 | 1,279.50 | 829.20 | 1,132.70 | 1,262.80 |
| EPS (Rs) | 15.67 | 7.73 | 4.33 | 4.04 | 8.51 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Other income | 616.90 | 160.90 | 79.60 | 99.10 | 80.80 |
| Stock adjustment | -70.00 | 81.10 | -19.30 | -27.60 | -82.90 |
| Raw material | 1,582.60 | 1,270.70 | 1,273.30 | 1,355.70 | 1,124.20 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 729.40 | 642.70 | 582.20 | 622.70 | 570.80 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1,082.60 | 1,161.90 | 1,197.20 | 1,079.60 | 1,023.90 |
| Provisions made | - | - | - | - | - |
| Depreciation | 246.10 | 247.10 | 242.80 | 235.90 | 223.00 |
| Taxation | 394.70 | 249.80 | 142.50 | 163.50 | 168.60 |
| Net profit / loss | 1,585.90 | 782.60 | 443.90 | 414.00 | 871.20 |
| Extra ordinary item | - | - | - | -319.30 | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 101.20 | 101.20 | 102.40 | 102.40 | 102.40 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 35.00 | 27.93 | 21.20 | 26.67 | 31.58 |
| GPM (%) | 38.85 | 28.18 | 21.10 | 26.77 | 32.10 |
| NPM (%) | 27.67 | 17.24 | 11.30 | 9.78 | 22.15 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis